Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

$7.8 Billion Molecular Diagnostics Market Positioned for Significant Growth

Published: Wednesday, July 10, 2013
Last Updated: Wednesday, July 10, 2013
Bookmark and Share
New analysis sizes the MDx market, analyzes key market drivers, and provides detailed forecasts through 2015 across major sectors.

G2 Intelligence announces the release of U.S. Molecular Diagnostic and Genomic Testing 2013-2015: Laboratory Industry Analysis, Trends, and Forecasts, a new resource for stakeholders in MDx testing. In conjunction with the release of the study, G2 currently gauges the MDx market at $7.8 billion in 2013.

“Like other health care sectors, molecular diagnostics is experiencing disruptive forces that are redefining the very core of care, delivery, and reimbursement models,” according to L. Eleanor Herriman, M.D. M.B.A., Managing Director of G2 Intelligence Advisory Services, and one of the report’s analysts. “These forces are largely driven by the reactions of health care payers and policy makers to the national health care cost crisis, and the shift to a value-based system. MDx is uniquely positioned to play a central role in value-based health care, but must first navigate some challenging regulatory and payer issues.”

U.S. Molecular Diagnostic and Genomic Testing clarifies the market with:

•    Market sizing and growth forecasts through 2015 across seven MDx sectors:
o    Hematology-Oncology (Hem-Onc)
o    Pharmacogenomics (PGx)
o    Women’s Health
o    General Infectious
o    Inherited
o    Transplant
o    Blood Screening

•    Analysis of key market drivers and inhibitors

•    Platform usage by test type including:

o    Abbott, ABI, Access, Autogenomics, BD (Becton, Dickinson and Company), Bio Rad Biocare, Cepheid, Dako, Focus, GenMark, Gen-Probe, Leica, Luminex Qiagen, Roche, Ventana and more

•    Menu availability and in-house vs. send out analysis, by test including:

o    Adenovirus, ALK, BCL-2, BCR/ABL, BK Virus, Bordetella, BRAF, C-Diff, Chlamydia/Gonorrhea, C-KIT, CMV Cytomegalovirus, Cystic Fibrosis, EBV (Epstein-Barr), EGFR, Enterovirus, FLT3, Group A Strep, Group B Strep,HBV Viral Load, HCV Viral Load and Genotyping, HER-2, Herpes (HSV), HIV Viral Load and Genotyping, HPV, HPV Genotyping, HPV non-cervical, Influenza A/B, JAK-2, KI-67, KRAS, MRSA or SA, Norovirus, Respiratory Virus, Trich, Tuberculosis, VRE, VZV (Varicella Zoster)

•    How and why Pharmacogenomics is poised to grow

•    Next Generation Sequencing challenges and solutions

•    And much more...

“Where there is volatility, there is opportunity,” says Jennifer Musumeci, MS, and Associate Director of G2’s Advisory Services. “While there is significant variability in growth rates within MDx sectors, the overall market will expand in 2013, despite the bumpy road in the short term. It’s essential for labs, IVD manufacturers, health care payers and providers to find out where they stand, and where these game-changing diagnostics are headed. This new report fills that void with a wealth of valuable data.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Diagnosing Bacterial Infections in Blood Samples
Researchers have diagnosed a bacterial infection from a blood sample in infants.
Neurodvelopmental Disorder Cause Linked to SON Gene
A genetic link has been discovered for a previously unxplained neurodevelopmental disorder.
World's Most In-Depth Study to Detect Alzheimer's Disease
A multisite team will see the most thorough and vigorous testing for Alzheimer's ever performed on volunteers.
Personalised Medicine: Dose by Design
Personalised medicine holds the promise of a new approach to healthcare, tailored exactly to our individual needs, as Congenica's Nick Lench discussed on a recent BBC Radio 4 programme.
Misdiagnosis in HCM Tests
Genetic tests for potentially fatal heart anomaly can misdiagnose condition in black Americans.
Computers Better Predict Lung Cancer Type, Severity
Study shows automating the analysis of cancer tissue samples increases the accuracy of tumor classification and patient prognoses.
Examining New Hypotheses for Undiagnosed Patients
UnDx Consortium gathers in San Diego to create new paths to identifying currently undiagnosed illnesses.
Automating Genetic Analysis
Researchers are looking to have computers help perform genetic analysis when scientists study a patient's genome to diagnose a disease.
Understanding Tumor Evolution
Study provides insight into tumor evolution; may point to improved diagnosis and treatment.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!